Market Research Logo

Global Interstitial Cystitis Drugs Market 2019-2023

Global Interstitial Cystitis Drugs Market 2019-2023

About this market

The advent of gene therapy to drive market growth. Interstitial cystitis is characterized by urinary urgency and frequency, pelvic pain, and nocturia. However, only a few approved treatments are available, and curable treatments for the disease have not been identified yet. Although the etiology of the disease is not fully understood, usually, a bladder affected by interstitial cystitis is characterized by a thin and denuded urothelium. Most of the approved drugs and off-label drugs are small molecules, and they cannot completely cure the disease. Moreover, owing to the side effects and high costs of the available drugs, companies can establish new innovative treatment options such as regenerative therapy and gene therapy that have fewer side effects. Companies are also trying to develop a drug that can completely cure the disease. Technavio’s analysts have predicted that the interstitial cystitis drugs market will register a CAGR of almost 3% by 2023.

Market Overview

Increasing awareness of interstitial cystitis

Although interstitial cystitis is one of the significantly prevalent bladder diseases, many people are unaware of it as most of the symptoms are very similar to other bladder-related diseases. Hence, educating people and making them aware of interstitial cystitis are very important. Many government and non-government organizations are conducting various programs to increase the awareness of the disease.

Lack of approved drugs

The treatment of interstitial cystitis consists of oral therapy and intravesical therapy as the first- and second-line treatment options, respectively. However, no single treatment works for all people with the disease. The treatment is based on the symptoms of each patient. Most of the patients try different treatments (or combinations of treatments) to get rid of the symptoms. Currently, the global interstitial cystitis drugs market has only two approved drugs, ELMIRON and RIMSO-50 (dimethyl sulfoxide). These drugs are proven their efficacy over the symptomatic treatments. However, these drugs are expensive. Therefore, many patients use off-label drugs largely to relieve the symptoms of the disease.

For the detailed list of factors that will drive and challenge the growth of the interstitial cystitis drugs market during the 2019-2023, view our report.

Competitive Landscape

The market appears to be fragmented and with the presence of several companies including Mylan N.V and Pfizer the competitive environment is quite intense. Factors such as the increasing awareness of interstitial cystitis and the advent of gene therapy, will provide considerable growth opportunities to interstitial cystitis drugs manufactures. Bayer AG, Eli Lilly and Company, Johnson & Johnson Services, Mylan N.V, and Pfizer are some of the major companies covered in this report.


PRESS RELEASE

Technavio Announces the Publication of its Research Report – Global Interstitial Cystitis Drugs Market 2019-2023

Technavio recognizes the following companies as the key players in the global interstitial cystitis drugs market: Bayer AG, Eli Lilly and Company, Johnson & Johnson Services, Mylan N.V, and Pfizer.

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is the advent of gene therapy.”

According to the report, one of the major drivers for this market is the increasing awareness of interstitial cystitis.

Further, the report states that one of the major factors hindering the growth of this market is the lack of approved drugs.

Companies Mentioned

Bayer AG

Eli Lilly and Company

Johnson & Johnson Services

Mylan N.V

and Pfizer

  • Executive summary
  • Scope of the report
    • Preface
    • Currency conversion rates for US$
  • Market landscape
    • Market ecosystem
      • Table Global pharmaceuticals market
      • Table Segments of global pharmaceuticals market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2018
      • Table Market size 2018
    • Market size and forecast 2018-2023
      • Table Global market: Size and forecast 2018-2023 ($ millions)
      • Table Global market: Year-over-year growth 2019-2023 (%)
  • Five forces analysis
    • Table Five forces analysis 2018
    • Table Five forces analysis 2023
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2018
  • Market segmentation by type
    • Table Type - Market share 2018-2023 (%)
    • Comparison by type
      • Table Comparison by type
    • Oral therapy - Market size and forecast 2018-2023
      • Table Oral therapy - Market size and forecast 2018-2023 ($ millions)
      • Table Oral therapy - Year-over-year growth 2019-2023 (%)
    • Intravesical therapy - Market size and forecast 2018-2023
      • Table Intravesical therapy - Market size and forecast 2018-2023 ($ millions)
      • Table Intravesical therapy - Year-over-year growth 2019-2023 (%)
    • Market opportunity by type
      • Table Market opportunity by type
  • Customer landscape
    • Table Customer landscape
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2018-2023 (%)
    • Geographic comparison
      • Table Geographic comparison
    • North America - Market size and forecast 2018-2023
      • Table North America - Market size and forecast 2018-2023 ($ millions)
      • Table North America - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in North America
    • Europe - Market size and forecast 2018-2023
      • Table Europe - Market size and forecast 2018-2023 ($ millions)
      • Table Europe - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in Europe
    • Asia - Market size and forecast 2018-2023
      • Table Asia - Market size and forecast 2018-2023 ($ millions)
      • Table Asia - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in Asia
    • ROW - Market size and forecast 2018-2023
      • Table ROW - Market size and forecast 2018-2023 ($ millions)
      • Table ROW - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in ROW
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision Framework
  • Drivers and challenges
    • Market drivers
      • Table Awareness programs related to interstitial cystitis
      • Table Funds for research on interstitial cystitis
    • Market challenges
      • Table Overlapping of the symptoms of interstitial cystitis
      • Table Impact of drivers and challenges
  • Market trends
    • Table Strategic alliances in the global interstitial cystitis drugs market
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
    • Competitive scenario
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Bayer AG
      • Table Bayer AG - Vendor overview
      • Table Bayer AG - Product segments
      • Table Bayer AG - Organizational developments
      • Table Bayer AG - Geographic focus
      • Table Bayer AG - Segment focus
      • Table Bayer AG - Key offerings
      • Table Bayer AG - Key customers
    • Eli Lilly and Company
      • Table Eli Lilly and Company - Vendor overview
      • Table Eli Lilly and Company - Business segments
      • Table Eli Lilly and Company - Organizational developments
      • Table Eli Lilly and Company - Geographic focus
      • Table Eli Lilly and Company - Segment focus
      • Table Eli Lilly and Company - Key offerings
      • Table Eli Lilly and Company - Key customers
    • Johnson & Johnson Services, Inc.
      • Table Johnson & Johnson Services, Inc. - Vendor overview
      • Table Johnson & Johnson Services, Inc. - Business segments
      • Table Johnson & Johnson Services, Inc. - Organizational developments
      • Table Johnson & Johnson Services, Inc. - Geographic focus
      • Table Johnson & Johnson Services, Inc. - Segment focus
      • Table Johnson & Johnson Services, Inc. - Key offerings
      • Table Johnson & Johnson Services, Inc. - Key customers
    • Mylan N.V.
      • Table Mylan N.V. - Vendor overview
      • Table Mylan N.V. - Business segments
      • Table Mylan N.V. - Organizational developments
      • Table Mylan N.V. - Geographic focus
      • Table Mylan N.V. - Key offerings
      • Table Mylan N.V. - Key customers
    • Pfizer Inc.
      • Table Pfizer Inc. - Vendor overview
      • Table Pfizer Inc. - Business segments
      • Table Pfizer Inc. - Organizational developments
      • Table Pfizer Inc. - Geographic focus
      • Table Pfizer Inc. - Segment focus
      • Table Pfizer Inc. - Key offerings
      • Table Pfizer Inc. - Key customers
  • Appendix
    • Research methodology
      • Table Validation techniques employed for market sizing
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report